This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.
| Name | Shares | Options |
|---|---|---|
| Flynn James E Through Deerfield Private Design Fund IV, L.P. | 1,943,423 | 0 |
| Flynn James E Through Deerfield Healthcare Innovations Fund, L.P. | 1,943,420 | 0 |
| Hamilton Thomas Edward | 190,130 | 0 |
| Flynn James E Through Deerfield Private Design Fund III, L.P. | 161,950 | 0 |
| Flynn James E Through Deerfield Special Situations Fund, L.P. | 95,983 | 0 |
| Flynn James E Through Deerfield Partners, L.P. | 36,753 | 0 |
| Flynn James E Through Deerfield International Master Fund, L.P. | 26,240 | 0 |
| Flynn James E Through Deerfield Partners, L.P. | 20,617 | 0 |
| STARR KEVIN P | 17,530 | 0 |
| Hughes Thomas E. | 10,437 | 22,916 |
| Goldberg Avi Y. | 4,477 | 0 |
| Heller Frances K | 3,996 | 0 |
| KIM DENNIS D | 1,786 | 0 |
| Allen Patricia L | 1,649 | 0 |
| Secor Alicia Held by Spouse | 333 | 0 |
| Barrett Peter | 0 | 8,300 |
| EVERETT WENDY | 0 | 0 |
| Booth Bruce | 0 | 0 |
| Deerfield International Master Fund, L.P. Through Deerfield International Master Fund, L.P. | 0 | 0 |
| LAMATTINA JOHN L | 0 | 0 |
| Hamilton Thomas Edward FA Life Sciences, Inc. | 0 | 0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 0 | 0 |
| Celano Michael | 0 | 84,100 |
| Daniel Thomas O | 0 | 8,300 |
| McDonough Cameron Geoffrey | 0 | 0 |
| Deerfield International Master Fund, L.P. Through Deerfield Special Situations Fund, L.P. | 0 | 0 |
| McVeigh Brian | 0 | 0 |
| Atlas Venture Fund VII L P | 0 | 0 |
| 0 | 0 | |
| Flynn James E Through Deerfield Management Company, L.P. | 0 | 0 |
| Secor Alicia | 0 | 0 |
| Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. | 0 | 0 |
| THIRD ROCK VENTURES LP | 0 | 0 |
| LEFF JONATHAN S | 0 | 8,300 |
| BEN-MAIMON CAROLE | 0 | 411,400 |
| Hatfield Jeffrey S. | 0 | 0 |
| Truitt Joseph | 0 | 8,300 |
| PEREZ ROBERT J See note | 0 | 0 |
| Loustau Patrick | 0 | 0 |
| THOMAS FRANK E | 0 | 8,300 |
| Deerfield Healthcare Innovations Fund, L.P. Through Chondrial Therapeutics Holdings, LLC | 0 | 0 |
| PEREZ ROBERT J | 0 | 0 |
| Singhal Priya | 0 | 0 |
| Deerfield International Master Fund, L.P. Through Deerfield Partners, L.P. | 0 | 0 |
While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price
| Name | Shares | Price | Date |
|---|
Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.
| Name | Shares | Price | Date |
|---|